HCPCS J-code
J2357: omalizumab
Omalizumab 5 mg
Code
J2357
Generic
omalizumab
Brands
Xolair
Drug class
Biologic drugs (mAbs and biosimilars)
Common denial patterns
- IgE level threshold
- Step therapy with ICS/LABA
Frequently asked questions
What is HCPCS J2357?
Omalizumab 5 mg
Why does insurance commonly deny J2357?
IgE level threshold; Step therapy with ICS/LABA.
What brand-name drug uses J2357?
Xolair.
Related
Appeal a J2357 denial
Upload the denial — we draft the appeal letter in 5 minutes citing the right clinical guideline.
Get started →Contact: hello@approvalhelp.com